FTI Consulting appointed Christina Morris as Senior Managing Director to expand AI-enabled healthcare capabilities, targeting a Software Lifecycle Engineering market forecast to grow from ~$235B in 2025 to ~$344B in 2028 at a 15.4% CAGR [2]. The hire arrives as 58.6% of SLE decision-makers mandate automated test coverage thresholds for AI-generated code reaching production [3], signaling that governance and compliance are now primary buying criteria in regulated industries. Morris brings 25+ years of pharmaceutical and life sciences transformation experience, positioning FTI to compete for high-value advisory engagements at the intersection of AI regulation and operational risk [1][1].
What is Covered in this Article
- FTI Consulting's appointment of Christina Morris as Senior Managing Director [1][1]
- Enterprise AI governance and compliance mandates in software lifecycle engineering [3][3]
- Software Lifecycle Engineering market growth trajectory and advisory opportunity [2]
- AI adoption maturity in software engineering organizations [3][4]
The News: FTI Consulting (NYSE: FCN) appointed Christina Morris as Senior Managing Director in its Healthcare Risk Management & Advisory practice within the Forensic and Litigation Consulting segment, effective October 1, 2026 [1][1]. Morris brings more than 25 years of experience helping global pharmaceutical and life sciences organizations modernize risk, regulatory compliance, and quality operations through technology-enabled transformation [1]. Her mandate at FTI covers applying automation, data, AI, and business process management to strengthen compliance, reduce operational risk, and improve audit readiness [1]. Before joining FTI, she led AI, GenAI, hyperautomation, and intelligent platform initiatives as a Managing Director at a Big Four firm, and has held senior roles at Hoverstate, FrontierBPM, and EY [1]. FTI reported $3.8 billion in revenues during fiscal year 2025 and employs more than 8,100 people across 32 countries [1].
FTI Bets on AI Governance Demand With Morris Healthcare Hire
Analyst Take: FTI's move is a direct response to a measurable shift in how regulated enterprises buy AI advisory services. Governance, compliance, and audit readiness have moved from afterthoughts to primary decision criteria, and Morris's background maps precisely to those requirements [1][1]. The appointment signals that FTI sees healthcare and life sciences as a high-conviction growth vector within a rapidly expanding market [2].
Governance Mandates Are Reshaping the Advisory Opportunity
Enterprise demand for AI governance tooling is no longer aspirational. The Futurum SLE Decision Maker Survey, 2H 2026 found that 58.6% of respondents (n=839) indicate that automated test coverage thresholds for AI-generated code reaching production are currently mandatory verification practices in their organizations [3]. Separately, 45.1% of the same cohort report having audit logging of agent actions in place [3]. These figures reflect the compliance pressure that pharmaceutical and life sciences organizations face from regulators, and they define the exact problem set Morris has spent her career solving. FTI's practice leader Wayne T. Gibson framed the hire around helping clients determine where AI and automation can create value and how those opportunities can be implemented responsibly at scale, which aligns directly with what the survey data shows buyers prioritizing [1].
Early-Stage AI Adoption Creates Sustained Advisory Runway
Despite broad tool adoption, most organizations remain at relatively early stages of AI integration in software engineering. The Futurum survey found that 47.2% of respondents (n=839) describe their dominant mode of AI use as individual developer assistance only, covering IDE completion and chat [3]. That figure sits alongside the fact that 60.1% of organizations (n=828) already use AI technologies in development, including code completion, AI test development, and AI agents, as reported in the Futurum SLE Decision Maker Survey [4]. The gap between broad tool adoption and mature, governed deployment is precisely where advisory firms capture value. For FTI, Morris's experience redesigning business processes and operating models through AI, hyperautomation, and intelligent platforms positions the firm to help healthcare clients close that gap responsibly [1][1].
Market Scale Validates the Talent Investment
The financial logic behind the hire is straightforward. The Software Lifecycle Engineering market is forecast to grow from approximately $235B in 2025 to approximately $344B in 2028, representing a 15.4% CAGR from 2025 to 2028 [2]. Healthcare and life sciences represent a disproportionately compliance-intensive slice of that market, where advisory engagements command premium fees and tend toward multi-year relationships. FTI, with $3.8 billion in fiscal year 2025 revenues and a global footprint spanning 32 countries [1], has the scale to pursue large, complex transformation programs. Adding a senior practitioner with Morris's specific combination of pharmaceutical industry depth and AI platform expertise sharpens the firm's ability to convert that market growth into billable engagements.
What to Watch
- Client engagement velocity: whether FTI announces pharma or life sciences AI transformation mandates in Q4 2026 or Q1 2027 that signal Morris's pipeline is converting
- Regulatory catalyst: FDA or EMA guidance updates on AI in regulated manufacturing or clinical operations that could accelerate client urgency and advisory spend
- Competitive positioning: how rival Big Four and boutique advisory firms respond with their own healthcare AI governance hires or service line expansions over the next two quarters
- Governance adoption curve: whether the share of enterprises with audit logging of agent actions [3] rises materially above 45.1% in the next SLE survey cycle, indicating market maturation and shifting advisory demand
Sources
1. FTI Consulting Appoints Christina Morris, Fticonsulting
2. 2H 2026 Software Lifecycle Engineering Market Sizing & Five-Year Forecast, Futurum Research, July 2026
3. 2H 2026 Software Lifecycle Engineering Global Enterprise Decision Maker Survey Report, Futurum Research, July 2026
4. 1H 2026 Software Lifecycle Engineering Decision Maker Survey Report, Futurum Research, January 2026
Disclosure: Futurum is a research and advisory firm that engages or has engaged in research, analysis, and advisory services with many technology companies, including those mentioned in this article. The author does not hold any equity positions with any company mentioned in this article.
Read the full Futurum Group Disclosure.
Other Insights from Futurum:
FTI Bets on Energy-AI Convergence With Fargis Hire
FTI Consulting's Q1 2026 Results Show Resilience Amid Rising Costs
Software Lifecycle Engineering Market Growth
Author Information
This content is written by a commercial general-purpose language model (LLM) along with the Futurum Intelligence Platform, and has not been curated or reviewed by editors. Due to the inherent limitations in using AI tools, please consider the probability of error. The accuracy, completeness, or timeliness of this content cannot be guaranteed. It is generated on the date indicated at the top of the page, based on the content available, and it may be automatically updated as new content becomes available. The content does not consider any other information or perform any independent analysis.
